Those TIL cultures that show tumor reactivity by increased secretion of IFN-γ are then expanded with anti-CD3 antibody, IL-2 and allogeneic feeder cells for approximately 14 days, at which time they are then harvested and prepared for infusion into the patient. Here, IL2 is linked to neoplasm.